In the past decade, China has seen an EV boom, thanks in part to government support. Buying an electric car has gone from a novel decision to a routine one; by late 2025, nearly 60% of new cars sold were electric or plug-in hybrids.
But as the batteries in China’s first wave of EVs reach the end of their useful life, early owners are starting to retire their cars, and the country is now under pressure to figure out what to do with those aging components.
The issue is putting strain on China’s still-developing battery recycling industry and has given rise to a gray market that often cuts corners on safety and environmental standards. National regulators and commercial players are also stepping in, but so far these efforts have struggled to keep pace with the flood of batteries coming off the road. Read the full story.
—Caiwei Chen
The AI doomers feel undeterred
It’s a weird time to be an AI doomer.This small but influential community believes, in the simplest terms, that AI could get so good it could be bad—very, very bad—for humanity.
The doomer crowd has had some notable success over the past several years: including helping shape AI policy coming from the Biden administration. But a number of developments over the past six months have put them on the back foot. Talk of an AI bubble has overwhelmed the discourse as tech companies continue to invest in multiple Manhattan Projects’ worth of data centers without any certainty that future demand will match what they’re building.
So where does this leave the doomers? We decided to ask some of the movement’s biggest names to see if the recent setbacks and general vibe shift had altered their views. See what they had to say in our story.
—Garrison Lovely
This story is part of our new Hype Correction package, a collection of stories designed to help you reset your expectations about what AI makes possible—and what it doesn’t. Check out the rest of the package.
Take our quiz on the year in health and biotechnology
In just a couple of weeks, we’ll be bidding farewell to 2025. And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs have expanded in scope, and there have been some real “omg” biotech stories from the fields of gene therapy, IVF, neurotech, and more.
Jessica Hamzelou, our senior biotech reporter, is inviting you to put your own memory to the test. So how closely have you been paying attention this year?
